NOV 03, 2016 9:00 AM PDT

KEYNOTE: Big data and the learning healthcare system: practical applications for the clinical laboratory

Speaker
  • Assistant Professor of Pathology Director, Point of Care Testing Associate Director, Chemical Pathology; University of Michigan Hospital
    Biography
      Dr. Lee Schroeder is currently Assistant Professor at the University of Michigan where he is Director of Point-of-Care Testing and Associate Director of Chemical Pathology. His academic focus is at the interface of clinical informatics and health services research, using decision analytic approaches to model and improve the impact of laboratory medicine. This has included research involving laboratory capacity and quality improvement of sub-Saharan African laboratories, modeling the impact of different testing algorithms on health outcomes, and data mining the electronic medical record to better understand the performance of point-of-care testing.

      Lee Schroeder completed his BA in physics at the University of Pennsylvania in 1995, his MD/PhD with an NIH Medical Scientist Training Program scholarship award at the University of California, San Diego in 2011, and his pathology residency at Stanford University in 2014. Lee currently serves as Co-Director of a Blue Cross Blue Shield funded pilot program to improve utilization of genetic testing for hereditary cancer syndromes and is member of the chemistry resource committee at the College of American Pathologists.

    Abstract

    The aim of the learning healthcare system is to leverage data stored in the electronic health record (EHR) to gain insights into and improve healthcare delivery. Laboratory testing represents the largest source of routinely formatted data in the EHR and is therefore readily accessible for mining. In this presentation I will be describing a variety of practical applications of EHR data analytics relevant to clinical laboratory practice and patient care. These will include automatic generation of institutional reference ranges, synthesis of test panel results with machine learning models, fine-grained characterization of point-of-care instrument accuracy, effects of in-vitro hemolysis on central laboratory testing results, and the use of in-silico simulations to put the findings in context. Taking care to account for implicit confounders present in retrospective studies, a wealth of data exists in the EHR that can be unlocked to aid in day-to-day management of the clinical laboratory as well as guide healthcare policy-making in general.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    Loading Comments...
    Show Resources